Factors influencing prescribing the first add-on disease-modifying antirheumatic drugs in patients initiating methotrexate for rheumatoid arthritis

Factors influencing prescribing the first add-on disease-modifying antirheumatic drugs in patients initiating methotrexate for rheumatoid arthritis

Background: Advances in Disease-Modifying Antirheumatic Drugs (DMARDs) have expanded the treatment landscape for Rheumatoid Arthritis (RA). Guidelines recommend adding either conventional synthetic (cs), biologic (b), or targeted synthetic (ts) DMARDs to methotrexate (MTX) for managing RA. Limited e...

Full description

Bibliographic Details
Main Authors: Yinan Huang, Satabdi Chatterjee, Sandeep K. Agarwal, Hua Chen, Michael L. Johnson, Rajender R. Aparasu
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Exploratory Research in Clinical and Social Pharmacy
Subjects:
Rheumatoid arthritis
Tumor necrosis factor inhibitor biologics
Combination therapy
Methotrexate
Biological disease-modifying antirheumatic drugs
Online Access:http://www.sciencedirect.com/science/article/pii/S266727662300077X

Internet

http://www.sciencedirect.com/science/article/pii/S266727662300077X

Similar Items